• Policy
• All Sandoz products removed from Korea’s reimb list
• by Lee, Tak-Sun Jul 26, 2023 05:41am

• Policy
• Yuhan’s low-dose atorvastatin combo receives reimb
• by Lee, Tak-Sun Jul 25, 2023 05:46am

• Policy
• Be aware of interstitial renal tubulitis when taking Vimovo
• by Lee, Hye-Kyung Jul 25, 2023 05:45am

• Policy
• Reimbursement extended for 18 Factor VIII hemophilia drugs
• by Kim, Jung-Ju Jul 24, 2023 05:26am

• Policy
• BMS makes 2nd voluntary price cut for Baraclude this year
• by Lee, Tak-Sun Jul 24, 2023 05:26am

• Policy
• Original for Parkinson's dz tx released are withdrawn
• by Lee, Tak-Sun Jul 21, 2023 05:41am

• Policy
• How Scemblix received reimb without negotiations
• by Lee, Tak-Sun Jul 21, 2023 05:40am

• Policy
• Evrysdi also subject to prior authorization for reimb
• by Lee, Tak-Sun Jul 20, 2023 05:35am

• Policy
• The more applications for pre-screening drugs, the higher
• by Lee, Tak-Sun Jul 20, 2023 05:34am

• Policy
• MFDS organizes a Clinical Trial Consultative Body
• by Lee, Tak-Sun Jul 19, 2023 05:20am